A Central Role for RAF -> MEK -> ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
Eric A Collisson, Christy L Trejo, Jillian M Silva, Shenda Gu, James E Korkola, Laura M Heiser, Roch-Philippe Charles, Brian A Rabinovich, Byron Hann, David Dankort, Paul T Spellman, Wayne A Phillips, Joe W Gray, Martin McMahon
Cancer Discovery | AMER ASSOC CANCER RESEARCH | Published : 2012
Awarded by NIH/NCI
Awarded by NHGRI
Awarded by Department of the Army
J.W. Gray has commercial research grants from GlaxoSmithKline, Pfizer, and Susan G. Komen for the Cure and is a consultant/advisory board member for New Leaf Ventures, Agendia, and KromaTiD. M. McMahon has a commercial research grant from the National Comprehensive Cancer Network. No potential conflicts of interest were disclosed by the other authors.A. Collisson is supported by NIH/NCI CA137153. Funds were provided by the Noren Fund for Pancreatic Cancer Research (to M. McMahon). W. A. Phillips is supported by project grants from the National Health and Medical Research Council of Australia. This research was supported by NIH/NCI Grants P50 CA 58207, U54 CA 112970, and NHGRI U24 CA 126551; by the Department of the Army, Award W81XWH-07-1-0663, to J.W. Gray. Funds were provided by the Noren and Hasbun Funds for Pancreatic Cancer Research, and NIH/NCI R01 CA121361 to M. McMahon.